The US Food and Drug Administration has approved a landmark eye drop that uses a combined dose of medication to restore ...
Eye drops for presbyopia represent a major opportunity for patients, but their reception by eye care professionals since the ...
Morning Overview on MSN
FDA clears 1st dual-action eye drop to fight age-related vision loss
Age-related near vision loss has long been treated as an inevitable annoyance of getting older, a slow erosion of clarity ...
Combining two eye drops that have been on the market for at least 30 years each has earned Tenpoint Therapeutics an FDA ...
The FDA approved a fixed-dose combination of carbachol and brimonidine tartrate for presbyopia, offering a noninvasive ...
The burden of presbyopia and reading glasses drives patients to look for solutions.“There is a clear and growing patient ...
Sarah Jessica Parker reveals how she is addressing age-related blurry vision. The "And Just Like That..." and "Sex and the City" star and avid reader is raising awareness of age-related vision loss ...
The biotech also raised $235 million in debt and equity funding to support marketing of the drop, which it claims to be an ...
YUVEZZI (TM) (carbachol and brimonidine tartrate ophthalmic solution) 2.75%/0.1% is a dual-agent eye drop approved by the U.S. Food & Drug Administration (FDA) for the treatment of presbyopia, a ...
The U.S. Food and Drug Administration has approved Yuvezzi (carbachol and brimonidine tartrate) ophthalmic solution 2.75%/0.1 ...
The FDA approved carbachol/brimonidine tartrate ophthalmic solution (Yuvezzi) for adults with presbyopia, marking the first ...
Yuvezzi, a combination cholinergic agonist and alpha-adrenergic agonist, is now FDA-approved as a once-daily treatment for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results